This inventor holds 3 USPTO granted patents. Top assignee: Academisch Ziekenhuis Leiden (h.o.d.n. Lumc). Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Huib Ovaa: Innovator in Cathepsin Inhibitors
Introduction
Huib Ovaa is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit cathepsin activity. With a total of three patents to his name, Ovaa's work is recognized for its potential impact on therapeutic applications.
Latest Patents
Ovaa's latest patents focus on cathepsin inhibitors. These inventions relate to compounds that are particularly useful as inhibitors of Cathepsin K (CatK). The patents detail methods of inhibiting cathepsin activity, which involve administering a compound or formulation that includes the innovative compounds developed by Ovaa.
Career Highlights
Huib Ovaa is affiliated with the Academisch Ziekenhuis Leiden, also known as LUMC. His work at this institution has allowed him to explore and develop his innovative ideas in a collaborative research environment. Ovaa's contributions to the field have been recognized through his patents, which reflect his commitment to advancing medical science.
Collaborations
Ovaa has worked alongside notable colleagues, including Maria Wilhelmina Elisabeth Mons and Stan Van Boeckel. These collaborations have likely enriched his research and contributed to the successful development of his patented inventions.
Conclusion
Huib Ovaa stands out as an influential inventor in the realm of cathepsin inhibitors. His work not only showcases his innovative spirit but also holds promise for future advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
